Tät®II app for treating urgency and mixed urinary incontinence
Implementation of the App Tät®II for Treatment of Urgency and Mixed Urinary Incontinence
This project will test whether using the Tät®II app for 15 weeks helps women 18 and older who have urgency or mixed urinary incontinence after a doctor's assessment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Umeå University Academic / other |
| Locations | 1 site (Östersund) |
| Trial ID | NCT07038811 on ClinicalTrials.gov |
What this trial studies
This observational implementation project invites women with doctor-diagnosed urgency or mixed urinary incontinence to use the Tät®II smartphone app for 15 weeks and complete online questionnaires at baseline, after treatment, and one year later. Participants are recruited via primary care waiting rooms, social media, and a research webpage, and eligibility is confirmed during a secure video meeting with the study team. Enrollment requires a recent medical record documenting the urinary incontinence diagnosis and absence of exclusion conditions such as pregnancy or recent childbirth. The study will monitor real-world feasibility of delivering first-line pelvic floor muscle and bladder training through the app across Sweden.
Who should consider this trial
Good fit: Women aged 18 or older with doctor-documented urgency or mixed urinary incontinence who can provide a recent medical record and consent to digital follow-up are ideal candidates.
Not a fit: Women who are pregnant, recently gave birth within six months, have painful urgency, difficulty emptying the bladder, visible blood in the urine, or need further urological investigation may not benefit from this app-based approach.
Why it matters
Potential benefit: If successful, this could give women an accessible home-based option to reduce urgency and mixed incontinence symptoms without extra clinic visits.
How similar studies have performed: Previous research on app- and home-based pelvic floor muscle training has shown symptom improvements for some types of urinary incontinence, though implementation after primary care is less well studied.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female gender * Age ≥18 years * Symptoms of urgency urinary incontinence or mixed urinary incontinence * Medical evaluation and documentation of urinary incontinence by ordinary doctor * Signed informed consent Exclusion Criteria: * Pregnancy * Childbirth in the last 6 months * Painful urges * Difficulties emptying the bladder * Blood in urine * Need of further investigation concerning the urinary incontinence, according to the clinical doctor
Where this trial is running
Östersund
- Region Jämtland Härjedalen — Östersund, Sweden (Recruiting)
Study contacts
- Principal investigator: Ina Asklund, MD, PhD — Umeå University
- Study coordinator: Annelie Olofsson, MD, PhD
- Email: annelie.olofsson@umu.se
- Phone: +46 70 54 58 116
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.